NYSE:PRX Pharmaceutical Resources (PRX) Stock Price, News & Analysis → This Apple-like Innovator is Revolutionizing Healthcare (From Wall Street Star) (Ad) Free PRX Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume277,372 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Pharmaceutical Resources alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Pharmaceutical Resources Stock (NYSE:PRX)Par Pharmaceutical Companies, Inc. is a holding company that, principally through its wholly owned operating subsidiary, Par Pharmaceutical, Inc., is in the business of developing, licensing, manufacturing, marketing and distributing generic and branded drugs in the United States. The Company operates primarily in the United States as two business segments: Par Pharmaceutical (Par), its generic products division, and Strativa Pharmaceuticals (Strativa), its branded products division. In February 17, 2012, the Company acquired Edict Pharmaceuticals Private Limited. On November 17, 2011, it acquired Anchen Incorporated and its subsidiary, Anchen Pharmaceuticals, Inc. In October 2011, it acquired rights to three products from Teva Pharmaceuticals in connection with Teva's acquisition of Cephalon. In September 2012, certain affiliates of TPG acquired the Company.Read More Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry PRX Stock News HeadlinesMarch 12, 2024 | msn.comPharmacies getting back on track after Change Healthcare hackFebruary 25, 2024 | msn.comARS Pharmaceuticals (SPRY) Price Target Increased by 56.25% to 12.75April 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.January 29, 2024 | tmcnet.comPharmaScroll Unveils Groundbreaking Expansion of Key Opinion Leader Database: Empowering Pharmaceutical Industry with Cutting-Edge Market InsightsJanuary 4, 2024 | msn.comIberdrola terminates $8.3bn PNM Resources mergerJanuary 2, 2024 | businesswire.comRocket Pharmaceuticals to Present at 42 nd Annual J.P. Morgan Healthcare ConferenceDecember 21, 2023 | msn.comCAN, CALT and PRZO are among pre market gainersNovember 26, 2023 | msn.comRecursion Pharmaceuticals Wants to 4X Its Supercomputing Power for AI With the Help of Nvidia. Here's Why It Matters.April 24, 2024 | Wall Street Star (Ad)This Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.October 24, 2023 | businesswire.comPre-Sterilized/Ready to Use Pharmaceutical Packaging Market, 2035 - ResearchAndMarkets.comOctober 24, 2023 | msn.com2 pharmaceutical companies to pay $120M in 3rd Kentucky settlementSeptember 26, 2023 | benzinga.comSpherix Introduces Patient Chart Dynamix™, an Enhanced Independent Pharmaceutical Market Research Chart AuditSeptember 15, 2023 | msn.comWhy Crinetics Pharmaceuticals Stock Soared This WeekSeptember 4, 2023 | businesswire.comPharmaceutical Temperature-Controlled Packaging Market, 2028 - Pharma TCP Market Digitization to Cut Costs and Streamline Processes - ResearchAndMarkets.comMay 17, 2023 | marketwatch.comGlobal Drug and Pharmaceutical Machinery Market 2023-2030 by Size|Precisionreports.coMay 14, 2023 | marketwatch.comPharmaceutical Cartridges Market by 2030May 11, 2023 | marketwatch.comPharmaceutical Labeling Market Research | 2023-2030May 11, 2023 | marketwatch.comPharmaceutical Inks Market Research | 2023-2030May 11, 2023 | marketwatch.comLatest Updates on Pharmaceutical outsourcing Market from Industry Experts | 2023 to 2030May 11, 2023 | marketwatch.comPharmaceutical Grade Dextran Market Future Scope and Growth Status 2031May 11, 2023 | msn.comChina Resources Pharmaceutical Group (3320) Price Target Increased by 10.39% to 8.07May 8, 2023 | marketwatch.comDrug and Pharmaceutical Machinery Market Size, 2030May 5, 2023 | marketwatch.comPharmaceutical Contract Packaging Market Research Findings to 2030May 5, 2023 | marketwatch.com2023 Pharmaceutical Equipment Market To Deliver Greater Revenues during the Forecast Period until 2030April 29, 2023 | marketwatch.comPharmaceutical Warehousing Market Demand by 2031April 28, 2023 | marketwatch.comPharmaceutical CRM Software Market Demand by 2031April 28, 2023 | marketwatch.comPharmaceutical Drugs for Therapy Market Growth by 2031See More Headlines Receive PRX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pharmaceutical Resources and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryN/A Current SymbolNYSE:PRX CUSIPN/A CIK878088 Webwww.parpharm.com Phone+1-845-5735500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesPaul V. Campanelli (Age 54)Chief Executive Officer Michael A. Tropiano (Age 57)Chief Financial Officer, Executive Vice President Terrance John Coughlin (Age 52)Chief Operating Officer Thomas J. Haughey (Age 51)Chief Administrative Officer, General Counsel PRX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Pharmaceutical Resources own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pharmaceutical Resources investors own include Gol Linhas Aéreas Inteligentes (GOL), WildHorse Resource Development (WRD), Baidu (BIDU), Amicus Therapeutics (FOLD), U.S. Global Investors (GROW), Inovio Pharmaceuticals (INO), Monster Beverage (MNST), Rite Aid (RAD), Rocket Companies (RKT) and (APKT) (APKT). This page (NYSE:PRX) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe Greatest Bull Market in Crypto History…Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharmaceutical Resources Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
